Xcenda Celebrates 25th Anniversary by Launching New Value & Market Access Solutions
Suite of new offerings uses digital innovation to better identify and evaluate evidence for enhanced strategic planning
FORT MILL, S.C.--(BUSINESS WIRE)-- Xcenda, a strategic consulting firm and part of AmerisourceBergen, continues to drive innovation by launching several new solutions designed to help pharmaceutical manufacturers differentiate their products and reach more patients.
“For the last 25 years, Xcenda’s goal has been to transform evidence, policy insights and market intelligence to help our clients tell their best data-driven value story,” said Xcenda President Kristine Flemister. “As the healthcare landscape evolves, we continue to seek out new ways to address some of our industry's most pressing challenges and support our clients in demonstrating therapy value, maximizing patient access, and increasing brand performance."
Xcenda consistently seeks out innovative solutions to help stakeholders make informed decisions that consider the clinical, economic, and humanistic outcomes of a product. Xcenda’s newest offerings include:
- MetaMap Pro: A first-of-its-kind digital tool that houses the totality of evidence extracted during a Systematic Literature Review (SLR), allowing global teams a greater ability to filter and analyze immense amounts of data for strategic planning. The new tool generates graphs, tables, and data visuals to easily incorporate into modeling and presentations. New studies can be added to the repository as available, creating an evergreen resource of trusted, comprehensive information.
- Interactive Exposure Model: Simply put, this new predictive tool helps manufacturers map the financial needs of their patient assistance programs. The interactive nature of the platform means users can update and evaluate assumption changes and test multiple scenarios in real-time to accommodate present and future program needs.
- VIP 2.0: Complementing Xcenda’s current facilitator-led offering - VIP (Value Identification Process), VIP 2.0 provides a digital platform to discuss, evaluate and rank go-to-market messages and relevant evidence to help develop value propositions and messages geared at payers for formulary decision-making. The tool enables a wider variety of stakeholders to input feedback and ideas digitally, alleviating the challenge of gathering all necessary personnel in the same room to decipher data and discuss strategy.
- PracticeLand™ Interactive Training Tool: An award-winning digital learning experience – for both individual and group use – designed to immerse players in real-life reimbursement and access scenarios. By compliantly tackling a variety of patient access challenges and provider reimbursement obstacles, participants experience better retention and knowledge application in real-life settings.
In addition to Xcenda’s 25th Anniversary, the company is also celebrating 20 years of its Fellowship Program, the longest-running consulting fellowship in the industry. Since its founding in 1999, 27 fellows have graduated from the program and nearly 75 percent of them are still with the company today. The two-year program allows fellows to explore different areas of interest and develop strong skill sets in a specialized area of expertise including, but not limited to, economic modeling, market research, value frameworks, outcomes analytics, and medical communications.
Founded in 1994, Xcenda was established with the vision that the healthcare conversation would ultimately shift to one focused on the value of different medical and pharmaceutical products. As such, Xcenda became a pioneer in generating credible and practical health economics and outcomes research to help manufacturers prove the value of emerging therapies, tell their best data-driven value story, and develop strategies that adapt to the changing payer and reimbursement landscapes.
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work—and powered by our 21,000 associates—we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500, with more than $160 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. Learn more at amerisourcebergen.com.
For more than 2 decades, companies have turned to Xcenda’s leading team of value experts, transforming evidence and market intelligence into effective global market access strategies and solutions. Founded in the application of health outcomes and reimbursement, it’s our goal to help prove the inherent worth of client products and services, maximize patient access, and enhance overall brand performance. Learn more at xcenda.com.